These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 22211589)
1. The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients. Rudkjøbing VB; Thomsen TR; Alhede M; Kragh KN; Nielsen PH; Johansen UR; Givskov M; Høiby N; Bjarnsholt T FEMS Immunol Med Microbiol; 2012 Jul; 65(2):236-44. PubMed ID: 22211589 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571 [TBL] [Abstract][Full Text] [Related]
3. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis. Flight WG; Smith A; Paisey C; Marchesi JR; Bull MJ; Norville PJ; Mutton KJ; Webb AK; Bright-Thomas RJ; Jones AM; Mahenthiralingam E J Clin Microbiol; 2015 Jul; 53(7):2022-9. PubMed ID: 25878338 [TBL] [Abstract][Full Text] [Related]
4. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Kehagia V; Connett GJ; Bruce KD J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392 [TBL] [Abstract][Full Text] [Related]
5. Bacterial activity in cystic fibrosis lung infections. Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Kehagia V; Jones GR; Bruce KD Respir Res; 2005 Jun; 6(1):49. PubMed ID: 15929792 [TBL] [Abstract][Full Text] [Related]
7. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis. Rudkjøbing VB; Thomsen TR; Alhede M; Kragh KN; Nielsen PH; Johansen UR; Givskov M; Høiby N; Bjarnsholt T J Clin Microbiol; 2011 Dec; 49(12):4352-5. PubMed ID: 22012018 [TBL] [Abstract][Full Text] [Related]
8. Assessment of sample handling practices on microbial activity in sputum samples from patients with cystic fibrosis. Nelson A; De Soyza A; Bourke SJ; Perry JD; Cummings SP Lett Appl Microbiol; 2010 Sep; 51(3):272-7. PubMed ID: 20629946 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients. Spasenovski T; Carroll MP; Payne MS; Bruce KD Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939 [TBL] [Abstract][Full Text] [Related]
12. PNA-based fluorescence in situ hybridization for identification of bacteria in clinical samples. Fazli M; Bjarnsholt T; Høiby N; Givskov M; Tolker-Nielsen T Methods Mol Biol; 2014; 1211():261-71. PubMed ID: 25218392 [TBL] [Abstract][Full Text] [Related]
13. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469 [TBL] [Abstract][Full Text] [Related]
14. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. Wellinghausen N; Köthe J; Wirths B; Sigge A; Poppert S J Clin Microbiol; 2005 Aug; 43(8):4070-5. PubMed ID: 16081953 [TBL] [Abstract][Full Text] [Related]
16. [Nocardia farcinica infection in a patient with cystic fibrosis]. Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956 [TBL] [Abstract][Full Text] [Related]
17. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period. Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361 [TBL] [Abstract][Full Text] [Related]
18. Assessing Airway Microbiota in Cystic Fibrosis: What More Should Be Done? LiPuma JJ J Clin Microbiol; 2015 Jul; 53(7):2006-7. PubMed ID: 25972422 [TBL] [Abstract][Full Text] [Related]
19. Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. Burmølle M; Thomsen TR; Fazli M; Dige I; Christensen L; Homøe P; Tvede M; Nyvad B; Tolker-Nielsen T; Givskov M; Moser C; Kirketerp-Møller K; Johansen HK; Høiby N; Jensen PØ; Sørensen SJ; Bjarnsholt T FEMS Immunol Med Microbiol; 2010 Aug; 59(3):324-36. PubMed ID: 20602635 [TBL] [Abstract][Full Text] [Related]